Literature DB >> 8477807

Interleukin-9 stimulates in vitro growth of mouse thymic lymphomas.

A Vink1, J C Renauld, G Warnier, J Van Snick.   

Abstract

The ability of interleukin (IL)-9 to stimulate the in vitro proliferation of freshly collected mouse thymic lymphoma cells was tested on a panel of 45 tumors, induced by N-methyl-N-nitrosourea (MNU) or by X-ray irradiation. IL-9 significantly stimulated the proliferation of 26 of these tumors. Out of 11 other factors tested, only IL-2, IL-4 and IL-7 showed similar activities. In addition to the responses to IL-9 alone, a potent synergy was often observed between IL-9 and IL-2 for MNU-induced tumors. Synergies between IL-9 and IL-7 or IL-9 and IL-4 were also observed but less frequently. The growth-promoting activity of IL-9 and the synergistic activities of IL-2 and IL-9 for thymic lymphoma cells were confirmed with cell lines established from the fresh tumors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8477807     DOI: 10.1002/eji.1830230523

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  5 in total

Review 1.  The development and in vivo function of T helper 9 cells.

Authors:  Mark H Kaplan; Matthew M Hufford; Matthew R Olson
Journal:  Nat Rev Immunol       Date:  2015-04-07       Impact factor: 53.106

2.  Interleukin 9 induces expression of three cytokine signal inhibitors: cytokine-inducible SH2-containing protein, suppressor of cytokine signalling (SOCS)-2 and SOCS-3, but only SOCS-3 overexpression suppresses interleukin 9 signalling.

Authors:  D Lejeune; J B Demoulin; J C Renauld
Journal:  Biochem J       Date:  2001-01-01       Impact factor: 3.857

3.  A single tyrosine of the interleukin-9 (IL-9) receptor is required for STAT activation, antiapoptotic activity, and growth regulation by IL-9.

Authors:  J B Demoulin; C Uyttenhove; E Van Roost; B DeLestré; D Donckers; J Van Snick; J C Renauld
Journal:  Mol Cell Biol       Date:  1996-09       Impact factor: 4.272

4.  Acute lymphoblastic leukemia-associated JAK1 mutants activate the Janus kinase/STAT pathway via interleukin-9 receptor alpha homodimers.

Authors:  Tekla Hornakova; Judith Staerk; Yohan Royer; Elisabetta Flex; Marco Tartaglia; Stefan N Constantinescu; Laurent Knoops; Jean-Christophe Renauld
Journal:  J Biol Chem       Date:  2009-01-12       Impact factor: 5.157

Review 5.  IL-9-producing T cells: potential players in allergy and cancer.

Authors:  Pornpimon Angkasekwinai; Chen Dong
Journal:  Nat Rev Immunol       Date:  2020-08-12       Impact factor: 53.106

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.